2022 What's Next for Asia-Pacific Endocrine Function Market for 20 Tests?—Opportunities in 18 Countries, Supplier Shares, Volume and Sales Segment Forecasts, Growth Strategies, Latest Technologies and Instrumentation Pipeline
August 25, 2022
VPG Market Research
0
PDF
2022 What's Next for Asia-Pacific Endocrine Function Market for 20 Tests?—Opportunities in 18 Countries, Supplier Shares, Volume and Sales Segment Forecasts, Growth Strategies, Latest Technologies and Instrumentation Pipeline
Abstract
The report is available in Local PDF, Global PDF, and Data Pack formats (supplier shares, test volumes, sales forecasts). The report is delivered in both Excel and PDF.
This new report from LeadingMarketResearch.com provides analysis of the endocrine function diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts, market shares and strategic profiles of leading suppliers.
The report is available by section, and can be customized to specific information needs and budget.
The report provides test volume and sales forecasts for the following assays:
1. Cortisol 2. Estradiol 3. Follicle-Stimulating Hormone (FSH) 4. Gastrin 5. Growth Hormone/IGF-1 6. Human Chorionic Gonadotropin (HCG) 7. LH 8. Progesterone 9. PTH/IO PTH 10. Prolactin 11. T3 12. T3 Free 13. T3 Uptake 14. T4 (Thyroxine) 15. T4 Free 16. TBG 17. Testosterone 18. Thyroglobulin Ab 19. TPO Ab 20. TSH
Country Analyses
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam
During the next decade, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
This report is designed to help current suppliers and potential market entrants to identify and evaluate emerging opportunities and developed effective strategic responses.
Content Table of Contents
I. Introduction II. Market and Technology Overview A. Selected Tests Clinical Significance and Diagnostic Procedures 1. Cortisol 2. Estradiol 3. Follicle-Stimulating Hormone (FSH) 4. Gastrin 5. Growth Hormone/IGF-1 6. Human Chorionic Gonadotropin (HCG) 7. LH 8. Progesterone 9. PTH/IO PTH 10. Prolactin 11. T3 12. T3 Free 13. T3 Uptake 14. T4 (Thyroxine) 15. T4 Free 16. TBG 17. Testosterone 18. Thyroglobulin Ab 19. TPO Ab 20. TSH B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers C. Major In Vitro Diagnostic Technologies and Their Potential Applications 1. Monoclonal and Polyclonal Antibodies 2. Immunoassays a. Technological Principle b. Chemiluminescence c. Enzyme Immunoassays (EIA) - Overview - ELISA - EMIT - Electrochemical d. Radioimmunoassays (RIA) e. Immunoprecipitation f. Affinity Chromatography 3. Tandem Mass Spec 4. IT and Automation 5. Dry Chemistry 6. Biosensors III. Market Size, Growth and Sales Forecasts by Test Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam IV. Major Product Development Opportunities V. Design Criteria for Decentralized Testing Products VI. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts D. Distribution Strategies for Decentralized Testing Markets 1. Marketing Approaches 2. Product Complexity 3. Customer Preference 4. Established Suppliers 5. Emerging Suppliers 6. Major Types of Distributors 7. Market Segmentation VII. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges VIII. Competitive Assessments Abbott Agilent Technologies Beckman Coulter/Danaher bioMerieux Bio-Rad DiaSorin Eiken Chemical Fujirebio Grifols Instrumentation Laboratory/Werfen Kyowa Medex Ortho-Clinical Diagnostics PerkinElmer Quest Diagnostics Roche Siemens Healthineers Sysmex Thermo Fisher Tosoh Wako
The report is available in Local PDF, Global PDF, and Data Pack formats (supplier shares, test volumes, sales forecasts). The report is delivered in both Excel and PDF.
This new report from LeadingMarketResearch.com provides analysis of the endocrine function diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts, market shares and strategic profiles of leading suppliers.
The report is available by section, and can be customized to specific information needs and budget.
The report provides test volume and sales forecasts for the following assays:
1. Cortisol 2. Estradiol 3. Follicle-Stimulating Hormone (FSH) 4. Gastrin 5. Growth Hormone/IGF-1 6. Human Chorionic Gonadotropin (HCG) 7. LH 8. Progesterone 9. PTH/IO PTH 10. Prolactin 11. T3 12. T3 Free 13. T3 Uptake 14. T4 (Thyroxine) 15. T4 Free 16. TBG 17. Testosterone 18. Thyroglobulin Ab 19. TPO Ab 20. TSH
Country Analyses
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam
During the next decade, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
This report is designed to help current suppliers and potential market entrants to identify and evaluate emerging opportunities and developed effective strategic responses.
Table of Contents
I. Introduction II. Market and Technology Overview A. Selected Tests Clinical Significance and Diagnostic Procedures 1. Cortisol 2. Estradiol 3. Follicle-Stimulating Hormone (FSH) 4. Gastrin 5. Growth Hormone/IGF-1 6. Human Chorionic Gonadotropin (HCG) 7. LH 8. Progesterone 9. PTH/IO PTH 10. Prolactin 11. T3 12. T3 Free 13. T3 Uptake 14. T4 (Thyroxine) 15. T4 Free 16. TBG 17. Testosterone 18. Thyroglobulin Ab 19. TPO Ab 20. TSH B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers C. Major In Vitro Diagnostic Technologies and Their Potential Applications 1. Monoclonal and Polyclonal Antibodies 2. Immunoassays a. Technological Principle b. Chemiluminescence c. Enzyme Immunoassays (EIA) - Overview - ELISA - EMIT - Electrochemical d. Radioimmunoassays (RIA) e. Immunoprecipitation f. Affinity Chromatography 3. Tandem Mass Spec 4. IT and Automation 5. Dry Chemistry 6. Biosensors III. Market Size, Growth and Sales Forecasts by Test Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam IV. Major Product Development Opportunities V. Design Criteria for Decentralized Testing Products VI. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts D. Distribution Strategies for Decentralized Testing Markets 1. Marketing Approaches 2. Product Complexity 3. Customer Preference 4. Established Suppliers 5. Emerging Suppliers 6. Major Types of Distributors 7. Market Segmentation VII. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges VIII. Competitive Assessments Abbott Agilent Technologies Beckman Coulter/Danaher bioMerieux Bio-Rad DiaSorin Eiken Chemical Fujirebio Grifols Instrumentation Laboratory/Werfen Kyowa Medex Ortho-Clinical Diagnostics PerkinElmer Quest Diagnostics Roche Siemens Healthineers Sysmex Thermo Fisher Tosoh Wako